NEW YORK, April 11, 2023 /PRNewswire/ -- The antacids market size is forecasted to increase by USD 712.45 million from 2021 to 2026, at a CAGR of 3.37%, according to the recent market study by Technavio. The growth of the market will be driven by the rising geriatric population, poor lifestyle patterns, and increasing use of non-steroidal anti-inflammatory drugs (NSAIDs).  Technavio offers an up-to-date analysis of the current global market scenario and the overall market environment. View a Sample Report.  

Vendor Analysis:

The global antacids market is expected to grow steadily during the forecast period. This growth is attributed to lifestyle factors, coupled with the overuse of medication and dietary supplements. Technavio has extensively analyzed 15 major vendors, including Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., iNova Pharmaceuticals, Johnson and Johnson, Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., United Natural Foods Inc., WellSpring Pharmaceutical Corp., and The Procter and Gamble Co.

Vendor Offerings -

• AmerisourceBergen Corp. - The company offers antacids that have a naturally made water-dissolving formula to cure acidity and heartburn, under the brand name American Health Packaging.

• Bayer AG - The company offers antacids that help neutralize excess stomach acids, offering fast, effective relief from indigestion and heartburn, under the brand name Rennie.

• Cardinal Health Inc. - The company offers antacids that give relief from heartburn, sour stomach, and acid indigestion and alleviate or relieve the symptoms of gas, under the brand name Cardinal Health.

For more insights on vendors and their offerings -  Request a Sample Report!

Key Benefits for Industry Players & Stakeholders – 

• The report offers information on the criticality of vendor inputs, including R&D, CAPEX, and technology.

• It also provides detailed analyses of the market's competitive landscape and vendors' product offerings.

• The report also provides a qualitative and quantitative analysis of vendors to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Expand operations in the future - To get requisite details, ask for a custom report.

Market Segmentation:

This antacids market research report extensively covers antacids market segmentation by type (non-symmetric antacids and symmetric antacids) and geography (North America, Europe, Asia, and Rest of World (ROW)).

• The market share growth by the non-systemic antacid segment will be significant during the forecast period. The non-systemic antacids segment is expected to grow at a moderate rate during the forecast period. This is due to the better efficacy demonstrated when used in combination. Additionally, the drugs used as combination therapies minimize the adverse effects and effectively treat GERD and acid reflux. These combinations are usually used as fast- and slow-acting pharmaceutical ingredients. For instance, magnesium hydroxide, which is a fast-acting ingredient, is typically used with aluminum hydroxide, which is a slow-acting ingredient.

Charts & data tables about market and segment sizes for forecast period (2022-
2026) have been covered in this report. Download The Sample Report

Antacids Market - Market Dynamics:

Key Drivers:

• The rising geriatric population is notably driving the antacids market growth during the forecast period. 

• The sphincter in the lower esophagus tends to relax with age, allowing acid to reflux or flow backward, causing heartburn. It can also be caused by GERD. Age is directly related to the increase in various disorders, which includes GERD.

• Moreover, advances in healthcare and advanced treatment options for various diseases increase the average life expectancy of people. For example, as per the US census bureau, in 2015, there were approximately 617 million people aged 65 years and above, and the number is expected to reach 1,566 million by 2050.

• According to the data collected by the World Bank and the NIH, the percentage of the aging population is expected to grow from 8.48% in 2016 to approximately 17% by 2050.

• Hence, such factors are expected to drive the antacids market growth in the forecast period.

Major Trends:

• The growing e-commerce market is one of the key antacids market trends.

• The global antacids market is witnessing a growing trend of online transactions, as the market is dominated by OTC drugs that require no prescription.

• The growth can be attributed to the increased popularity of e-commerce retailing and retailers' efforts on improving the online shopping experience through better online education and targeted marketing.

• The strong viability of e-commerce channels is expected to further stimulate the sales of antacids.

• Furthermore, online retailers offer free access to various online offers. For instance, Amazon offers the option of different billing and shipping addresses.

• Hence, it is observed that online facilities encourage consumers to buy medicines online, thereby stimulating market growth.

Key Challenges:

• A key challenge hampering the global antacids market growth is the adverse effect of prolonged use of antacids.

• Many antacids such as Maalox, Mylanta, Rolaids, and TUMS contain calcium, when taken in high doses, can expose patients to a risk of calcium overdose. This leads to adverse effects such as nausea, kidney stones, and swelling of the feet.

• Antacids consisting of aluminum hydroxide may cause constipation, aluminum intoxication, osteocalcin, and hypophosphatemia.

• Moreover, the availability of OTC antacids and their combined use with other medications may result in drug-drug interactions and have serious side effects. For instance, antacids, when taken with acidic drugs such as digoxin or chlorpromazine, may result in drug absorption. Due to this, the concentration of the drug in the blood becomes low, which further reduces the efficacy of the drug.

• Hence, the adverse effects of antacids may impede the growth of the antacids market during the forecast period.

To get detailed insights about inclusions and exclusions, buy the report 

What are the key data covered in this Antacids Market report?

• CAGR of the market during the forecast period

• Detailed information on factors that will drive the growth of the antacids market between 2022 and 2026

• Precise estimation of the size of the antacids market and its contribution to the parent market

• Accurate predictions about upcoming trends and changes in consumer behavior

• Growth of the antacids market across North America, Europe, Asia, and Rest of World (ROW)

• A thorough analysis of the market's competitive landscape and detailed information about vendors

• Comprehensive analysis of factors that will challenge the growth of the antacids market vendors

Gain instant access to 17,000+ market research reports. 
Technavio's SUBSCRIPTION platform

Related Reports:

The aluminum hydroxide market size has the potential to grow by USD 672.37 million during 2020-2025, and the market's growth momentum will accelerate at a CAGR of 4%. This report provides a detailed analysis of the market by application (chemical, flame retardant, filler, antacid, and others), geography (APAC, North America, Europe, South America, and MEA), and key vendors. The rising demand for antacids is one of the key factors expected to fuel the aluminum hydroxide market growth during the forecast period.

The Gastroesophageal Reflux Disease (GERD) Market size is estimated to grow by USD 908.49 million between 2022 and 2027. The size of the market is expected to increase at a CAGR of 3.4%. Technavio has divided the market into route of administration (oral and parenteral), type (antacid, PPI, H2 receptor antagonist drugs, and pro-kinetic drugs), and geography (Antacid, PPI, H2 receptor antagonist drugs, and pro-kinetic drugs). The rise of the geriatric population will drive the gastroesophageal reflux disease market growth.

Browse for Technavio's Health Care Market Reports  

Table of contents 

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition

• 3.2 Market segment analysis

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026

4 Five Forces Analysis

• 4.1 Five forces summary

• 4.2 Bargaining power of buyers

• 4.3 Bargaining power of suppliers

• 4.4 Threat of new entrants

• 4.5 Threat of substitutes

• 4.6 Threat of rivalry

• 4.7 Market condition

5 Market Segmentation by Type

• 5.1 Market segments

• 5.2 Comparison by Type

• 5.3 Non-symmetric antacids - Market size and forecast 2021-2026

• 5.4 Symmetric antacids - Market size and forecast 2021-2026

• 5.5 Market opportunity by Type

6 Customer Landscape

• 6.1 Customer landscape overview

7 Geographic Landscape

• 7.1 Geographic segmentation

• 7.2 Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026

• 7.4 Europe - Market size and forecast 2021-2026

• 7.5 Asia - Market size and forecast 2021-2026

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026

• 7.7 US - Market size and forecast 2021-2026

• 7.8 Germany - Market size and forecast 2021-2026

• 7.9 Canada - Market size and forecast 2021-2026

• 7.10 UK - Market size and forecast 2021-2026

• 7.11 Brazil - Market size and forecast 2021-2026

• 7.12 Market opportunity by geography

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape

• 9.3 Landscape disruption

• 9.4 Industry risks

10 Vendor Analysis

• 10.1 Vendors covered

• 10.2 Market positioning of vendors

• 10.3 AmerisourceBergen Corp.

• 10.4 Bayer AG

• 10.5 Cardinal Health Inc.

• 10.6 GlaxoSmithKline Plc

• 10.7 Humco Holding Group Inc.

• 10.8 Johnson and Johnson

• 10.9 Novartis AG

• 10.10 Sanofi SA

• 10.11 Sun Pharmaceutical Industries Ltd.

• 10.12 WellSpring Pharmaceutical Corp.

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist

• 11.3 Currency conversion rates for US$

• 11.4 Research methodology

• 11.5 List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/antacids-market-size-to-grow-at-a-cagr-of-3-37-from-2021-to-2026--driven-by-the-rising-geriatric-population---technavio-301793215.html

SOURCE Technavio